Growth Metrics

IDEAYA Biosciences (IDYA) Cash from Investing Activities (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Cash from Investing Activities for 7 consecutive years, with -$97.5 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 50.52% to -$97.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.0 million through Dec 2025, up 113.92% year-over-year, with the annual reading at $70.0 million for FY2025, 113.92% up from the prior year.
  • Cash from Investing Activities hit -$97.5 million in Q4 2025 for IDEAYA Biosciences, down from $41.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $79.8 million in Q1 2025 to a low of -$354.0 million in Q1 2024.
  • Historically, Cash from Investing Activities has averaged -$34.7 million across 5 years, with a median of -$14.0 million in 2022.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 2388.14% in 2022 and later skyrocketed 374.83% in 2023.
  • Year by year, Cash from Investing Activities stood at -$413000.0 in 2021, then crashed by 2388.14% to -$10.3 million in 2022, then tumbled by 989.36% to -$111.9 million in 2023, then crashed by 76.08% to -$197.1 million in 2024, then soared by 50.52% to -$97.5 million in 2025.
  • Business Quant data shows Cash from Investing Activities for IDYA at -$97.5 million in Q4 2025, $41.8 million in Q3 2025, and $45.9 million in Q2 2025.